Non-interventional Study Describing Treatment Convenience in Patients Treated With Dabigatran for Stroke Prophylaxis in Atrial Fibrillation (SPAF)

Trial Profile

Non-interventional Study Describing Treatment Convenience in Patients Treated With Dabigatran for Stroke Prophylaxis in Atrial Fibrillation (SPAF)

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 04 May 2017

At a glance

  • Drugs Dabigatran etexilate (Primary)
  • Indications Stroke
  • Focus Therapeutic Use
  • Acronyms SPAF
  • Sponsors Boehringer Ingelheim
  • Most Recent Events

    • 28 Apr 2017 Planned End Date changed from 1 Jul 2017 to 30 Oct 2017.
    • 28 Apr 2017 Planned primary completion date changed from 1 Jul 2017 to 30 Oct 2017.
    • 26 Jul 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top